The first of its kind in the region, the Neonatal and Pediatric Transport team launched under the direction of Mildred T. Stahlman, MD, a neonatal medicine pioneer who created the first modern NICU in 1961. The goal: to give babies a fighting chance.

The research may lead to new treatments for diseases such as inflammatory bowel disease and mucositis, a severe complication of chemotherapy.

NASPAG provides multidisciplinary leadership in education, research, advocacy and clinical care to improve the reproductive health of youth.

The goal of the wearable technology is to improve behavioral assessment of children with intellectual and developmental disabilities by predicting the precursors of problem behaviors and using that information to adjust therapeutic approaches.

VUMC’s antibody collaboration with the DOD goes back to 2018, when the medical center signed a five-year cooperative agreement with the U.S. Defense Advanced Research Projects Agency to develop protective treatments that can be rushed to health care providers within weeks after a viral outbreak.

She will be honored Aug. 17 during the TNAAP Excellence in Pediatrics Annual Awards, which recognize pediatricians and community members who have made exceptional contributions to children’s health advocacy in Tennessee.

Recognized as a major regional referral center for heart, kidney and liver transplantation, incorporating pancreas and lung transplant services for pediatric patients bolsters the well-established expertise currently offered by the Vanderbilt Transplant Center.